| Client | Syntro Health |
| Project | Sterile Cleanroom Facility |
| Location | Melbourne |
| Principal Contractor | BIO Construct Services |
| Build Year | 2025 |
| Duration | 6 Months |
| Project Value | $1.9 Million |
| Project Manager | Steve Dawson |
Business Overview
Syntro Health is a leading global provider of Investigational Medicinal Product (IMP) services, specialising in cGMP manufacturing, secure storage, clinical distribution and direct-to-patient solutions across Phase I–IV clinical trials. Their commitment to quality and regulatory excellence supports pharmaceutical and biotechnology partners in accelerating therapies from development to patients worldwide.
Project Scope & Responsibilities
BIO Construct Services was engaged to deliver a turnkey sterile cleanroom facility, overseeing the full lifecycle from early planning through to operational readiness. Our team managed every stage of delivery, including concept development, engineering coordination, approvals, construction, fit-out, commissioning and certification.
The works were delivered under an open book cost-plus model, providing Syntro Health with full transparency and the flexibility to refine facility requirements as operational needs evolved — all while maintaining continuity of business operations.
Our project scope included:
- Comprehensive design coordination, engineering reviews and authority permitting
- Delivery of all construction components using BIO Construct’s in-house specialists
- Procurement, coordination and management of specialist subcontractor services
- Construction and validation of a sterile, high-performance cleanroom environment aligned with pharmaceutical and regulatory standards
- Commissioning, testing and certification to meet industry compliance requirements
Key Highlights & Challenges
A critical early phase of the project involved supporting Syntro Health in evaluating multiple potential premises. BIO Construct Services assessed infrastructure suitability, compliance capability and long-term operational alignment to ensure the selected site would support future growth.
Through our in-house delivery model, core construction works were self-performed, allowing enhanced quality control, cost management and safety oversight throughout the build.
Operating within a complex regulatory environment required detailed planning and coordination across planning, engineering and compliance authorities to ensure seamless progression from design through certification.
The facility was delivered to stringent pharmaceutical standards, supporting Syntro Health’s advanced IMP manufacturing and handling operations within a precision-controlled sterile environment.
The Outcome
BIO Construct Services successfully delivered a state-of-the-art sterile cleanroom facility purpose-built to support Syntro Health’s mission of advancing high-quality IMP solutions worldwide. The result is a modern, compliant and future-ready environment that enhances operational efficiency, expands capability and supports continued innovation.
Gallery
